# Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia

> **NCT00000170** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 419 (actual)

## Conditions studied

- Amblyopia

## Interventions

- **DRUG:** Atropine
- **DEVICE:** Eye Patch

## Key facts

- **NCT ID:** NCT00000170
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2001-11
- **Final completion:** 2013-08
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2014-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000170, "Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00000170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*